144 related articles for article (PubMed ID: 37103742)
21. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
[TBL] [Abstract][Full Text] [Related]
23. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M
Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021
[TBL] [Abstract][Full Text] [Related]
24. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer.
Beenken SW; Urist MM; Zhang Y; Desmond R; Krontiras H; Medina H; Bland KI
Ann Surg; 2003 May; 237(5):732-8; discussion 738-9. PubMed ID: 12724640
[TBL] [Abstract][Full Text] [Related]
25. Comparison of survival outcomes between axillary conservation and axillary lymph node dissections in N1 early breast cancer: a propensity-matched SEER analysis.
Wu N; Su X; Tan Q; Luo J; Yuan Y; Hou L; Li J
Clin Transl Oncol; 2023 Apr; 25(4):1091-1101. PubMed ID: 36515887
[TBL] [Abstract][Full Text] [Related]
26. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
[TBL] [Abstract][Full Text] [Related]
27. [Lymph node metastasis regularity and risk factors in 768 cardiac carcinoma patients].
Yue J; Duan X; Gong L; Zhang J; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1283-1287. PubMed ID: 29178100
[TBL] [Abstract][Full Text] [Related]
28. A proposed staging system for primary gastric lymphoma.
Shimodaira M; Tsukamoto Y; Niwa Y; Goto H; Hase S; Hayakawa T; Nagasaka T
Cancer; 1994 Jun; 73(11):2709-15. PubMed ID: 8194010
[TBL] [Abstract][Full Text] [Related]
29. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy.
Atahan IL; Ozyigit G; Yildiz F; Gurkaynak M; Selek U; Sari S; Hayran M
Breast J; 2008; 14(3):245-9. PubMed ID: 18433402
[TBL] [Abstract][Full Text] [Related]
30. Development and Validation of a Preoperative Scoring System to Distinguish Between Nonadvanced and Advanced Axillary Lymph Node Metastasis in Patients With Early-stage Breast Cancer.
Murata T; Watase C; Shiino S; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
Clin Breast Cancer; 2021 Aug; 21(4):e302-e311. PubMed ID: 33303370
[TBL] [Abstract][Full Text] [Related]
31. Should all breast cancer patients with four or more positive lymph nodes who underwent modified radical mastectomy be treated with postoperative radiotherapy? A population-based study.
Wang H; Kong L; Zhang C; Chen D; Zhu H; Yu J
Oncotarget; 2016 Nov; 7(46):75492-75502. PubMed ID: 27690343
[TBL] [Abstract][Full Text] [Related]
32. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
33. Oncologic results of laparoscopic D3 lymphadenectomy for male sigmoid and upper rectal cancer with clinically positive lymph nodes.
Liang JT; Huang KC; Lai HS; Lee PH; Sun CT
Ann Surg Oncol; 2007 Jul; 14(7):1980-90. PubMed ID: 17458586
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
Singh D; Mandal A
Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
[TBL] [Abstract][Full Text] [Related]
35. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
[TBL] [Abstract][Full Text] [Related]
36. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
[TBL] [Abstract][Full Text] [Related]
37. Role of skip N2 lymph node metastasis for patients with the stage III-N2 lung adenocarcinoma: a propensity score matching analysis.
Wang S; Xie S; Han Y; Gao M; Su X; Liu Q
BMC Pulm Med; 2023 Apr; 23(1):147. PubMed ID: 37118722
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
39. The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.
Werntz RP; Riedinger CB; Fantus RJ; Smith ZL; Packiam VT; Adamsky MA; Smith N; Steinberg GD
Urol Oncol; 2018 Dec; 36(12):526.e1-526.e6. PubMed ID: 30446445
[TBL] [Abstract][Full Text] [Related]
40. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
